|
|
|
|
| LEADER |
03136nam a2200505 4500 |
| 001 |
978-3-319-89390-7 |
| 003 |
DE-He213 |
| 005 |
20191023161305.0 |
| 007 |
cr nn 008mamaa |
| 008 |
180904s2018 gw | s |||| 0|eng d |
| 020 |
|
|
|a 9783319893907
|9 978-3-319-89390-7
|
| 024 |
7 |
|
|a 10.1007/978-3-319-89390-7
|2 doi
|
| 040 |
|
|
|d GrThAP
|
| 050 |
|
4 |
|a QH506
|
| 072 |
|
7 |
|a MBGR
|2 bicssc
|
| 072 |
|
7 |
|a SCI049000
|2 bisacsh
|
| 072 |
|
7 |
|a MBGR
|2 thema
|
| 072 |
|
7 |
|a PSD
|2 thema
|
| 082 |
0 |
4 |
|a 611.01816
|2 23
|
| 245 |
1 |
0 |
|a Inflammasomes: Clinical and Therapeutic Implications
|h [electronic resource] /
|c edited by Mario D. Cordero, Elísabet Alcocer-Gómez.
|
| 250 |
|
|
|a 1st ed. 2018.
|
| 264 |
|
1 |
|a Cham :
|b Springer International Publishing :
|b Imprint: Springer,
|c 2018.
|
| 300 |
|
|
|a VIII, 400 p. 63 illus., 26 illus. in color.
|b online resource.
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a computer
|b c
|2 rdamedia
|
| 338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
| 347 |
|
|
|a text file
|b PDF
|2 rda
|
| 490 |
1 |
|
|a Experientia Supplementum,
|x 1664-431X ;
|v 108
|
| 505 |
0 |
|
|a Chapter 1: Bases of the inflammasomes in the clinical practice. A brief introduction -- Chapter 2: The Inflammasomes in Cardiovascular Disease -- Chapter 3: Inflammasomes in CNS diseases -- Chapter 4: Lung Diseases -- Chapter 5: Traumatic Injury -- Chapter 6: Inflammasome in the pathogenesis of pulmonary diseases -- Chapter 7: Inflammasome and Oral Diseases -- Chapter 8: Inflammasomes in the kidney -- Chapter 9: Pro-inflammatory actions of red blood cell-derived DAMPs -- Chapter 10: Role of Inflammasomes in the Development of Gastrointestinal Diseases -- Chapter 11: Inflammasomes in bone diseases -- Chapter 12: Inflammasome in Cancer -- Chapter 13: Aging and the inflammasomes -- Chapter 14: Genetics of inflammasome -- Chapter 15: Therapeutic implications of the inflammasomes.
|
| 520 |
|
|
|a This volume focuses on the role of inflammasomes in a variety of diseases and their therapeutic options. It gives an overview of the current studies elucidating the molecular implications in the medical and clinical contexts. It covers inflammasomes as potential therapeutic targets and evaluates the benefits of inflammasome inhibitors. .
|
| 650 |
|
0 |
|a Molecular biology.
|
| 650 |
|
0 |
|a Medical biochemistry.
|
| 650 |
1 |
4 |
|a Molecular Medicine.
|0 http://scigraph.springernature.com/things/product-market-codes/B1700X
|
| 650 |
2 |
4 |
|a Medical Biochemistry.
|0 http://scigraph.springernature.com/things/product-market-codes/H35005
|
| 700 |
1 |
|
|a Cordero, Mario D.
|e editor.
|4 edt
|4 http://id.loc.gov/vocabulary/relators/edt
|
| 700 |
1 |
|
|a Alcocer-Gómez, Elísabet.
|e editor.
|4 edt
|4 http://id.loc.gov/vocabulary/relators/edt
|
| 710 |
2 |
|
|a SpringerLink (Online service)
|
| 773 |
0 |
|
|t Springer eBooks
|
| 776 |
0 |
8 |
|i Printed edition:
|z 9783319893891
|
| 776 |
0 |
8 |
|i Printed edition:
|z 9783319893914
|
| 776 |
0 |
8 |
|i Printed edition:
|z 9783030077587
|
| 830 |
|
0 |
|a Experientia Supplementum,
|x 1664-431X ;
|v 108
|
| 856 |
4 |
0 |
|u https://doi.org/10.1007/978-3-319-89390-7
|z Full Text via HEAL-Link
|
| 912 |
|
|
|a ZDB-2-SBL
|
| 950 |
|
|
|a Biomedical and Life Sciences (Springer-11642)
|
